Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
about
First-line treatment of ovarian cancer: questions and controversies to address.Effect of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on relapse pattern in primary epithelial ovarian cancer: a propensity score based case-control study.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and gastrointestinal peritoneal carcinomatosis: results from a 7-year experience.Hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer.Wounding promotes ovarian cancer progression and decreases efficacy of cisplatin in a syngeneic mouse model.
P2860
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
@en
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
@nl
type
label
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
@en
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
@nl
prefLabel
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
@en
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
@nl
P2093
P50
P356
P1476
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
@en
P2093
Arend G J Aalbers
Harm van Tinteren
Henriëtte J Arts
Ignace H J T de Hingh
Jacobien M Kieffer
Jacobus van der Velden
Jules H Schagen van Leeuwen
Karolina Sikorska
Koen K Van de Vijver
Leon F A G Massuger
P304
P356
10.1056/NEJMOA1708618
P407
P577
2018-01-01T00:00:00Z